You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Zimmer (ZBH) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Read MoreHide Full Article
Zimmer Biomet (ZBH - Free Report) reported $1.94 billion in revenue for the quarter ended June 2024, representing a year-over-year increase of 3.9%. EPS of $2.01 for the same period compares to $1.82 a year ago.
The reported revenue represents a surprise of +0.19% over the Zacks Consensus Estimate of $1.94 billion. With the consensus EPS estimate being $1.98, the EPS surprise was +1.52%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Zimmer performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Net Sales- Knees- International
: $359.90 million compared to the $342.67 million average estimate based on four analysts. The reported number represents a change of +7.9% year over year.
Net Sales- Hips- International
: $247.50 million compared to the $253.26 million average estimate based on four analysts. The reported number represents a change of -1% year over year.
Net Sales- International
: $835.80 million compared to the $805.11 million average estimate based on four analysts. The reported number represents a change of +4.4% year over year.
Net Sales- Hips- United States
: $259 million versus $261.76 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +1.9% change.
Net Sales- United States
: $1.11 billion compared to the $1.13 billion average estimate based on four analysts. The reported number represents a change of +3.5% year over year.
Net Sales- Knees- United States
: $441.20 million versus $455.89 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +0.8% change.
Net Sales- Knees
: $801.10 million compared to the $802.43 million average estimate based on eight analysts. The reported number represents a change of +3.9% year over year.
Net Sales- Other
: $164.90 million compared to the $155.94 million average estimate based on eight analysts. The reported number represents a change of +9.1% year over year.
Net Sales- S.E.T
: $469.50 million compared to the $465.47 million average estimate based on eight analysts. The reported number represents a change of +6.1% year over year.
Net Sales- Hips
: $506.50 million versus $513.91 million estimated by eight analysts on average. Compared to the year-ago quarter, this number represents a +0.4% change.
Shares of Zimmer have returned +3.6% over the past month versus the Zacks S&P 500 composite's -5.9% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
In-Depth Zacks Research for the Tickers Above
Normally $25 each - click below to receive one report FREE:
Zimmer Biomet (ZBH - Free Report) reported $1.94 billion in revenue for the quarter ended June 2024, representing a year-over-year increase of 3.9%. EPS of $2.01 for the same period compares to $1.82 a year ago.
The reported revenue represents a surprise of +0.19% over the Zacks Consensus Estimate of $1.94 billion. With the consensus EPS estimate being $1.98, the EPS surprise was +1.52%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Zimmer performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
View all Key Company Metrics for Zimmer here>>>Net Sales- Knees- International
: $359.90 million compared to the $342.67 million average estimate based on four analysts. The reported number represents a change of +7.9% year over year.Net Sales- Hips- International
: $247.50 million compared to the $253.26 million average estimate based on four analysts. The reported number represents a change of -1% year over year.Net Sales- International
: $835.80 million compared to the $805.11 million average estimate based on four analysts. The reported number represents a change of +4.4% year over year.Net Sales- Hips- United States
: $259 million versus $261.76 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +1.9% change.Net Sales- United States
: $1.11 billion compared to the $1.13 billion average estimate based on four analysts. The reported number represents a change of +3.5% year over year.Net Sales- Knees- United States
: $441.20 million versus $455.89 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +0.8% change.Net Sales- Knees
: $801.10 million compared to the $802.43 million average estimate based on eight analysts. The reported number represents a change of +3.9% year over year.Net Sales- Other
: $164.90 million compared to the $155.94 million average estimate based on eight analysts. The reported number represents a change of +9.1% year over year.Net Sales- S.E.T
: $469.50 million compared to the $465.47 million average estimate based on eight analysts. The reported number represents a change of +6.1% year over year.Net Sales- Hips
: $506.50 million versus $513.91 million estimated by eight analysts on average. Compared to the year-ago quarter, this number represents a +0.4% change.Shares of Zimmer have returned +3.6% over the past month versus the Zacks S&P 500 composite's -5.9% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.